Komori
KYORIN Pharmaceutical (4569) · PolicyRestated

Fair Disclosure and Communication with Stakeholders

First written in FY2017. 3 of 4 entries say "Restated". Latest entry: FY2024.

4entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20242017: 120172018: 120182019: 120192020: 020202021: 020212022: 020222023: 020232024: 12024
Same theme, other companies
Compliance as a Listed Company and Timely, Appropriate Information DisclosureA theme 106 companies write about · 0 as a headwind · 107 as a tailwind

65 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 106 companies compared. The sentences above are computed from all 106.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.